Adverse Events Following Immunization (AEFI) in Nursing Science Program Sam Ratulangi University Students Based on the Type of COVID-19 Vaccine
DOI:
https://doi.org/10.20956/icon.v7i2.23638Keywords:
Covid-19, Vaccine, AEFIAbstract
Aims: The purpose of this study is to describe Adverse Events Following Immunization (AEFI) among Nursing Science Program Sam Ratulangi University students based on the type of Covid-19 vaccination that they received.
Methods: This investigation was conducted using a descriptive retrospective study approach. Purposive sampling was utilized to choose the sample for this study, which included 183 undergraduate students in the Nursing Science Program Sam Ratulangi University.
Results: After receiving the first dosage of the vaccination, Nursing Science Program Sam Ratulangi University students most frequently reported headache and muscle pain (30.4%), followed by pain and weakness in the injected arm (20.8%), and swelling at the injection site (26%). Additionally, there were students who received doses 1, 2, and 3 of the vaccination who did not exhibit any side effects. These students were 45 at dosage I, 73 at dose II, and 45 at dose III. At dose 1, the majority of Nursing Science Program Sam Ratulangi University students (73.2%) exhibited AEFI symptoms for less than a day, at doses II and III, 43.7% and 31.1%, respectively, reported experiencing symptoms for one to three days.
Conclusion: Based on the research that has been done, it can be said that Nursing Science Program Sam Ratulangi University students only encounter mild AEFI symptoms. So it is hoped that the general public or students won't have to worry about the COVID 19 vaccine causing AEFI symptoms and can get vaccinated right away to strengthen their immunity against the virus.
References
Bestari, N. P. (2021). This is a Side Effect of the Astra Zeneca Vaccine in Indonesia. Vaccine Word.
BPOM. (2021). Fact Sheet for Health Care Providers Emergency Use Authorization (Eua) of Bamlanivimab Authorized Use.
CDC Covid-19. (2021). Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer BioNTech Covid-19 Vaccine — United States, December 14–23, 2020. Food and Drug Administration, 70(2), 46–51. https://doi.org/ghrx2m
Doria, A., Zen, M., Bettio, S., Gatto, M., Bassi, N., Nalotto, L., Ghirardello, A., Iaccarino, L., & Punzi, L. (2012). Autoinflammation and autoimmunity: bridging the divide. Autoimmunity reviews, 12(1), 22–30. https://doi.org/10.1016/j.autrev.2012.07.018
Hadinegoro. (2000). Kejadian Ikutan Pasca Imunisasi. Sari Pediatri, 2(1), 2. https://doi.org/10.14238/sp2.1.2000.2-10
Hasibuan, L. (2021, June 16). Ini Beda AstraZeneca & Sinovac, Efikasi Hingga Efek Samping. CNBC. https://www.cnbcindonesia.com/tech/20210616153617-37-253633/ini-beda-astrazeneca-sinovac-efikasi-hingga-efek-samping
Hendra, H. H. (2020). Peran Imunoterapi pada Tatalaksana Alergi Makanan (The Role of Immunotherapy in Food Allergy). Jurnal Kedokteran Raflesia, 6(2), 19–28. https://doi.org/10.33369/juke.v6i2.13217
KPCPEN. (2021, December). Data on the Distribution of COVID-19 Vaccines. https://covid19.go.id/vaksin-covid19
Lidiana, E., Mustikasari, H., Pradana, K., & Permatasari, A. (2021). Gambaran Karakteristik Kejadian Ikutan Pasca Imunisasi COVID-19 pada Tenaga Kesehatan Alumni Universitas Surakarta. Jurnal Ilmu Kesehatan, 11(1), 11–17.
Kemenkes. (2021). Frequently Asked Questions Seputar Pelaksanaan Vaksinasi Covid-19. https://kesmas.kemkes.go.id/assets/uploads/contents/others/FAQ_VAKSINASI_COVID__call_center.pdf
Prawesti, P. (2021, January 1). Vaksin Covid-19: Efek Samping yang Dirasakan Nakes Indonesia yang divaksin di Inggris, hanya 'pegal linu'. BBC. https://www.bbc.com/indonesia/dunia-55467309
Rahayu, R. N. & Sensusiyati. (2021). Vaksin Covid 19 di Indonesia : Analisis Berita Hoax. Jurnal Ekonomi, Sosial & Humaniora, 2(7), 39–49. https://www.jurnalintelektiva.com/index.php/jurnal/article/view/422
Shimabukuro, T. (2021). Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine — United States, December 14–23, 2020. American Journal of Transplantation, 21(3), 1332–1337. https://doi.org/10.1111/ajt.16516
Siddik, I. R. (2021). Kehalalan Vaksin Covid-19 Produksi Sinovac dalam Fatwa MUI dan Implementasi Vaksinasinya Pada Tenaga Kesehatan di Puskesmas Tanjung Morawa, Deli Serdang (Perspektif Qawaidh Fiqhiyyah). Al-Mashlahah Jurnal Hukum Islam Dan Pranata Sosial, 9(01), 59–83.
Silbernagl, S., & Lang, F. (2016). Color Atlas of Pathophysiology (3rd Ed.). Thieme. https://doi.org/10.1055/b-005-148940
WHO. (2021, April 23). The Latest Covid-19 Data in Indonesia. https://data.who.int/dashboards/covid19/data
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
